Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Feb;18(2):226-231.
doi: 10.1111/j.1468-1331.2010.03154.x.

Positron emission tomography imaging in multiple sclerosis-current status and future applications

L Kiferle  1   2 , M Politis  1 , P A Muraro  1 , P Piccini  1
Affiliations
Review

Positron emission tomography imaging in multiple sclerosis-current status and future applications

L Kiferle et al. Eur J Neurol. 2011 Feb.

Abstract

Background: Multiple Sclerosis (MS) is traditionally considered as a central nervous system (CNS) white matter inflammatory disease. However, recent studies have focused on the neurodegenerative aspects of the disease, which occur early in the pathological process, providing an opportunity for therapeutic intervention and application of neuroprotective strategies. The relationship between neural inflammation and cell death remains controversial. The recent development of new radiolabelled ligands provides positron emission tomography (PET) imaging with a role for studying early aspects of the MS pathology.

Methods: We provide an overview of current PET research in MS, particularly focussing on possible applications of new radioligands for studying inflammation and neurodegenerative processes.

Results: Pathological aspects of neuroinflammation, axonal degeneration and neuronal repair may be explored in vivo with selective PET tracers. Specific radioligands for the cannabinoid system may be applied in MS research to understand the role of this neurotransmitter system in the pathogenesis of the disease.

Conclusions: PET imaging represents a promising tool for elucidating controversial aspects of MS pathology and for the assessment of selective and potentially neuroprotective therapies.

PubMed Disclaimer

References

    1. Trapp BD, Nave KA. Multiple sclerosis: an immune or Neurodegenerative disorder? Ann Rev Neurosci 2008; 31: 247-269.
    1. Lopez-Diego RS, Weiner HL. Novel therapeutic strategies for multiple sclerosis-a multifaceted adversary. Nat Rev Drug Discov 2008; 7: 909-925.
    1. Pozzilli C, Fieschi C, Perani D, et al. Relationship between corpus callosum atrophy and cerebral metabolic asymmetries in multiple sclerosis. J Neurol Sci 1992; 112: 51-57.
    1. Sørensen PS, Jønsson A, Mathiesen HK, et al. The relationship between MRI and PET changes and cognitive disturbances in MS. J Neurol Sci 2006; 245: 99-102.
    1. Blinkenberg M, Jensen CV, Holm S, Paulson OB, Sorensen PS. A longitudinal study of cerebral glucose metabolism, MRI, and disability in patients with MS. Neurology 1999; 53: 149-153.

LinkOut - more resources